Paper8617869
Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.
Gilles JG and 4 others. J Clin Invest, 1996. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A. Papers, record 8617869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8617869
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Anti-Idiotypic | Major topic |
| Desensitization, Immunologic | Major topic |
| Factor VIII | Major topic |
| Hemophilia A | Major topic |
| Adolescent | |
| Humans | |
| Immunotherapy |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3101065 | Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3101065 | PubMed |
| 2 | 3103425 | Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates. | Am J Hematol | 1987 | https://conductscience.org/library/papers/3103425 | PubMed |
| 3 | 3122859 | The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors. | Blood | 1988 | https://conductscience.org/library/papers/3122859 | PubMed |
| 4 | 3147154 | Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins. | Clin Exp Immunol | 1988 | https://conductscience.org/library/papers/3147154 | PubMed |
| 5 | 7691260 | Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. | Blood | 1993 | https://conductscience.org/library/papers/7691260 | PubMed |
| 6 | 3096366 | Disappearance of factor VIII:C antibodies in patients with haemophilia A upon frequent administration of factor VIII in intermediate or low dose. | Br J Haematol | 1986 | https://conductscience.org/library/papers/3096366 | PubMed |
| 7 | 7974364 | Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee. | Thromb Haemost | 1994 | https://conductscience.org/library/papers/7974364 | PubMed |
| 8 | 4140517 | Regulation of immune response by autogenous antibody against receptor. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4140517 | PubMed |
| 9 | 6418874 | Induction of tolerance to factor VIII in a child with a high-titer inhibitor: in vitro and in vivo observations. | J Pediatr | 1984 | https://conductscience.org/library/papers/6418874 | PubMed |
| 10 | 6377574 | Differentiation of thrombin- and factor Xa-related amidolytic activity in plasma by means of a synthetic thrombin inhibitor. | Thromb Res | 1984 | https://conductscience.org/library/papers/6377574 | PubMed |
| 11 | 6148519 | Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. | Lancet | 1984 | https://conductscience.org/library/papers/6148519 | PubMed |
| 12 | 7523452 | Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies. | J Clin Invest | 1994 | https://conductscience.org/library/papers/7523452 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36074992 | Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication. | Blood Adv | 2023 | https://conductscience.org/library/papers/36074992 | PubMed |
| 33898928 | Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A. | Hemasphere | 2021 | https://conductscience.org/library/papers/33898928 | PubMed |
| 32117285 | Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor. | Front Immunol | 2020 | https://conductscience.org/library/papers/32117285 | PubMed |
| 30545924 | Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A. | Haematologica | 2019 | https://conductscience.org/library/papers/30545924 | PubMed |
| 30514798 | Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance? | Haematologica | 2019 | https://conductscience.org/library/papers/30514798 | PubMed |
| 28920105 | The impact of von Willebrand factor on factor VIII memory immune responses. | Blood Adv | 2017 | https://conductscience.org/library/papers/28920105 | PubMed |
| 19160072 | Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies. | Clin Rev Allergy Immunol | 2009 | https://conductscience.org/library/papers/19160072 | PubMed |
| 16091456 | High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors. | Blood | 2005 | https://conductscience.org/library/papers/16091456 | PubMed |
| 8617864 | Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8617864 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F8 | 2157 | PubTator's text mining | https://conductscience.org/library/genes/2157 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8617869
GET https://conductscience.org/api/papers/v1/8617869/authors